FOP News

Exciting News from BioCryst Pharmaceuticals

BioCryst launches Phase 1 trial for FOP

Read more Share

An Important Announcement from Blueprint Medicines & Ipsen

Ipsen and Blueprint enter exclusive agreement in FOP

Read more Share

ASBMR 2019 Presentations

11 FOP Presentations Will Be Made At The Annual Meeting

Read more Share

Dr. Maurizio Pacifici’s Research Inspired Two Clinical Trials

Learn how research on RAR gamma agonists motivated the Palovarotene clinical trials  

Read more Share

Translational Research Program in Pediatric Orthopaedics, The Children's Hospital of Philadelphia (CHOP)

Read more Share

Interested in Participating in an FOP Research Study?

Blueprint Medicines conducting a one-time research study and looking for volunteers

Read more Share

A message from the ICC on FOPCon

Posted on behalf of the Clinical Trials Committee of the International Clinical Council on FOP (ICC)

Read more Share

Updated FOP Treatment Guidelines Released

The 2019 edition of the FOP Treatment Guidelines is now available

Read more Share

27th Annual Report of the FOP Collaborative Research Project

The 27th Annual Report is Now Available!

Read more Share

Blueprint Medicines Presents Preclinical Data Supporting the Development of an FOP Treatment Drug, BLU-782

Shared at the 2018 American Society of Bone and Mineral Research Meeting

Read more Share

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter